|Values are valid only on day of printing.|
September 10-12, 2014
Mayo Civic Center
Mayo Clinic Gonda Vascular Center,
Divisions of Cardiovascular Diseases and Hematology,
Department of Internal Medicine
Mayo Medical Laboratories
In Cooperation with Mayo Continuing Nursing Education
An estimated 37 million patients are affected by thrombotic disorders each year. This number will continue to rise with the increase in our aging population. This conference focuses on clinically applicable and cutting-edge methods used in the evaluation and treatment of patients with arterial and venous thrombotic disorders.
New this year, we have expanded our course to include an overview of vascular medicine content. This additional material will provide elements useful for providers caring for patients with a broad range of vascular diseases. The format of this content will also assist physicians preparing for the American Board of Vascular Medicine (ABVM) certification/recertification examinations. Lectures and case studies will be presented by Mayo Clinic faculty with ample opportunity to ask questions and discuss difficult diagnostic or management issues. Study questions will be covered during the conference.
Upon completion of the conference, participants should be able to:
This program is designed for practicing clinicians, primary care providers, hematologists, cardiologists, obstetricians and gynecologists, nurses, laboratory scientists and technologists, and vascular medicine and surgery specialists whose practices and interests include aspects of thrombotic disorders.
Attendance at this Mayo conference does not indicate nor guarantee competence or proficiency in the performance of any procedures that may be discussed or taught in this course.
The Clinical and Laboratory Update in Thrombosis, Anticoagulation and Vascular Medicine will be held September 10-12, 2014 (Wednesday–Friday). Course headquarters will be located in the Exhibit Hall at the Mayo Civic Center in Rochester, Minnesota. Meeting facilities are easily accessible by skyway.